Cyclosporin: some aspects of its mode of action. A review.
Aszalos
A
A
Division of Drug Biology, Food and Drug Administration, Washington, D.C. 20204.
D055592:Biophysical Phenomena; D001703:Biophysics; D002118:Calcium / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D003524:Cyclosporins / Q000494:pharmacology*; D004798:Enzymes / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007425:Intracellular Membranes / Q000378:metabolism
D002352:Carrier Proteins; D003524:Cyclosporins; D004798:Enzymes; D007166:Immunosuppressive Agents; D002118:Calcium